# Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns

> **NCT01870206** · PHASE3 · UNKNOWN · sponsor: **Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.** · enrollment: 320 (estimated)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Trivalent OPV Birmex
- **BIOLOGICAL:** Trivalent OPV Sanofi Pasteur

## Key facts

- **NCT ID:** NCT01870206
- **Lead sponsor:** Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2013-12
- **Final completion:** 2014-01
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2013-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01870206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01870206, "Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01870206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*